AR
Arumugam Ramachandran
About Arumugam Ramachandran
Data last updated:
Arumugam Ramachandran is a Director at Probionxt Engineering Private Limited (since 2022), Director at Komal Bioengineering Private Limited (since 2023) and Designated Partner at R S Pharmaconsol Limited Liability Par Tership (since 2024). The companies operate in Healthcare, Paper and Infrastructure and Utilities. The 2 current companies with reported revenue have a combined latest revenue of ₹6.01 Cr; the largest is Probionxt Engineering Private Limited at ₹6.00 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Jun 2022 | 2022 | ₹6.00 Cr (FY 2025) | Active | |
| Director | 21 Mar 2023 | 2023 | ₹1.2 Lakh (FY 2025) | Active | |
| Designated Partner | 30 Jan 2024 | 2021 | Active |
Board colleagues of Arumugam Ramachandran
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ramasamy Janaki Thilothsuriya | 09441231 | Probionxt Engineering Private Limited , R S Pharmaconsol Limited Liability Par Tership | Director |
| Kunal Kamal Chokshi | 02304712 | Komal Bioengineering Private Limited | Director |
| Nakul Kamal Chokshi | 06369298 | Komal Bioengineering Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Arumugam Ramachandran
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arumugam Ramachandran
Arumugam Ramachandran currently holds 3 directorships: Probionxt Engineering Private Limited (Director, since 24 Jun 2022, revenue ₹6.00 Cr (FY 2025)); Komal Bioengineering Private Limited (Director, since 21 Mar 2023, revenue ₹1.2 Lakh (FY 2025)); R S Pharmaconsol Limited Liability Par Tership (Designated Partner, since 30 Jan 2024).
Arumugam Ramachandran was first appointed on 24 Jun 2022 as Director at Probionxt Engineering Private Limited. The most recent appointment on record is 30 Jan 2024 at R S Pharmaconsol Limited Liability Par Tership.
The 2 current companies of Arumugam Ramachandran that report revenue have a combined latest revenue of ₹6.01 Cr: Probionxt Engineering Private Limited ₹6.00 Cr (FY 2025); Komal Bioengineering Private Limited ₹1.2 Lakh (FY 2025).
The current boards of Arumugam Ramachandran's companies include Ramasamy Janaki Thilothsuriya (Probionxt Engineering Private Limited), Kunal Kamal Chokshi (Komal Bioengineering Private Limited), Nakul Kamal Chokshi (Komal Bioengineering Private Limited).